Conditions: Acute Upper Respiratory Tract Infections
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 306
Healthy volunteers: no

Brief summary:
The purpose of this study is:

* to assess safety of the liquid dosage form of Ergoferon for treatment of acute upper respiratory tract infections in children;
* to assess clinical efficacy of the liquid dosage form of Ergoferon for treatment acute upper respiratory tract infections in children.

Detailed description:
The overall duration of a patient's participation in the trial is 6 days (screening/randomization, therapy onset - day 1; study therapy period - 5 days; follow-up period-1 day).

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Ergoferon intervention 2: Placebo
Intervention descriptions: intervention 1: Safety and Efficiency of liquid dosage form intervention 2: Safety and Efficiency of liquid dosage form

Protocol document: